Views & Analysis | Perspectives on pharma industry issues

Skip to main content

Wednesday 9 September 2026

BlueSky linkedin youtube

header links

Get Newsletters
Media Kit

Pharmaphorum menu first category

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
Spotlight on
Events

close

SECTION

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

Channels

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

SUB NAVIGATION

Live Coverage
Partner Content
About us
Work for us
Contribute
Contact us
Advertise

Newsletters and Deep Dive digital magazine

youtube linkedin BlueSky

Sales & Marketing

HCPs, DOLs

Sponsored

Local voices, global reach

Digital Opinion Leaders with regional followings are shaping prescribing behaviour in ways that international Key Opinion Leaders are not.

Sales & Marketing

Omnideployment concept, female hand holds digital globe and connected networks of men and women

Beyond omnichannel: Why pharma commercialisation must shift ...

We need to step away from the passive, broad concept of omnichannel and adopt a far more active, disciplined framework: omnideployment.

Digital

AI in clinical rials and drug development

AI in clinical trials: Building better trials before they st...

With AI, trial sponsors are now reducing risk, accelerating timelines, and driving innovation by modelling what is most likely to work in the future.

Digital

pharmaphorum podcast Episode 274, Erik Janssen, UCB

Sponsored

Ethical AI & trust-driven innovation: UCB’s Erik Janssen

How can pharma lead the way in ethical AI and trust-driven innovation?

Digital

Digital lock - cyber security concept - black background

Cyber resilience: Protecting tomorrow's therapies before the...

As investors place increasing emphasis on operational maturity alongside scientific excellence, cyber resilience must become part of the conversation.

Articles

Asthma and COPD patient adherence: the right inhaler

Asthma and COPD patient adherence: the right inhaler

Large numbers of hospital admissions, along with poor adherence and the prescribing of inappropriate inhalers mean that asthma and chronic obstructive pulmonary disease (COPD) are a huge burden

Articles

Earlier diagnosis - The key to improving Britain's cancer survival rates

Earlier diagnosis - The key to improving Britain's cancer su...

John Baron MP, chairman of the All Party Parliamentary Group on Cancer talks to pharmaphorum about the drive to improve the UK's poor record in early cancer diagnosis.

Articles

NICE backs full NHS funding for Alexion's Soliris

NICE backs full NHS funding for Alexion's Soliris

UK health watchdog NICE has given its blessing to NHS funding for Alexion's Soliris, a treatment for an ultra-rare genetic disorder, which is said to be the most expensive drug in the world.

Load more results

Sales & Marketing

Sales & Marketing

HCPs, DOLs

Sponsored

Local voices, global reach

Digital Opinion Leaders with regional followings are shaping prescribing behaviour in ways that international Key Opinion Leaders are not.

Sales & Marketing

Omnideployment concept, female hand holds digital globe and connected networks of men and women

Beyond omnichannel: Why pharma commercialisation must shift ...

We need to step away from the passive, broad concept of omnichannel and adopt a far more active, disciplined framework: omnideployment.

Digital

Digital

AI in clinical rials and drug development

AI in clinical trials: Building better trials before they st...

With AI, trial sponsors are now reducing risk, accelerating timelines, and driving innovation by modelling what is most likely to work in the future.

Digital

pharmaphorum podcast Episode 274, Erik Janssen, UCB

Sponsored

Ethical AI & trust-driven innovation: UCB’s Erik Janssen

How can pharma lead the way in ethical AI and trust-driven innovation?

Market Access

Market Access

European flags

The EU Joint Clinical Assessment in practice: Early lessons

Unfortunately, much of the discussion around the JCA has focused on how the framework is intended to operate, rather than how it works in practice.

Market Access

EU AI Act concept

Navigating Europe's AI regulatory labyrinth: A strategic gui...

For US drug developers, bringing AI tools across the Atlantic introduces steep regulatory hurdles.

Editor's Picks

Novartis halts CAR-T trials after patient deaths

White House signs pricing deals with nine more pharmas

Enhertu OK ends 10-year EU gap in frontline breast cancer

Roche taps Simcere for autoimmune trispecific for $1.53bn

Hutchmed rises on $1.3bn KRAS licensing deal with GSK

Newsletters and Deep Dive
digital magazine

Get Newsletters

Get in-depth news, opinions, and features on pharma and healthcare sent straight to your inbox

Oncology

Oncology

Representation of embryonic stem cells

Bridging the innovation gap: Scalable cell therapies, adapti...

Biotech must build manufacturing and trial models that make cell therapies scalable, accessible & commercially viable.

Oncology

Cancer cell

Building a Phase I oncology centre

The question is not whether an institution should ultimately develop Phase Ia capability. It is when the organisation is ready.

Oncology

leukaemia

Key lessons from EHA 2026: Translating evidence into impact

Across four days in Sweden, EHA 2026 offered a clear view of the future of blood cancer care.

Patients

Patients

Woman in yellow jacket blows nose due to hayfever

Redefining the self-care pathway in the evolving hayfever la...

When it comes to hayfever, proactive approach improves patient health literacy and empowers individuals to put their health back in their own hands.

Patients

Pharmacist hands woman prescription medicine with an explanation

Specialty medication access hinges on a 48-hour window

The vast majority of healthcare providers (HCPs) say that PA-related delays directly harm patient outcomes.

Patients

Man lies on floor next to spilled pill bottle, reference to overdose

Decline in overdose deaths ≠ The end of the opioid crisis

Since 2001, International Overdose Day has been observed as a moment to remember those lost to overdose and renew society’s commitment to

R&D

R&D

Digital pill, molecules inside, and digital hand with precision laser

Scientists and algorithms: Finding the right balance in mode...

The future of drug development is not scientists versus algorithms. It is scientists and algorithms working together.

R&D

Pill manufacturing line

Back to basics: X-ray inspection in pharmaceutical and medic...

In pharma manufacturing, x-ray inspection supports a range of quality control processes.

R&D

Green breathing concept

Decarbonising respiratory care requires a new kind of generi...

Generics manufacturers have long played a critical role in supporting the sustainability of the NHS, delivering affordable medicines at scale, expanding patient access, and helping healthca

Editor's Picks

Novartis halts CAR-T trials after patient deaths

White House signs pricing deals with nine more pharmas

Enhertu OK ends 10-year EU gap in frontline breast cancer

Roche taps Simcere for autoimmune trispecific for $1.53bn

Hutchmed rises on $1.3bn KRAS licensing deal with GSK

News

Pharvaris

Pharvaris plans filings for HAE drug after pivotal trial win

Pharvaris has reported positive data from a phase 3 trial of its drug for preventing HAE attacks, setting up marketing applications next year.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

Discover a new era of healthcare panel engagement

Sponsored

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Pharmaphorum Menu

Digital
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Market Access
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Oncology
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Patients
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
R&D
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Sales & Marketing
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Spotlight on

Sign up for email newsletters and Deep Dive

Get Newsletters

youtube linkedin BlueSky

About us Advertising Contact us

Contribute Cookie Policy Privacy Policy

Terms & Conditions Work for us

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2026, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2026, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company